ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,701 | -11.4% | 173,196 | +0.4% | 0.02% | -10.7% |
Q2 2023 | $5,304 | -12.3% | 172,554 | +2.8% | 0.03% | -17.6% |
Q1 2023 | $6,048 | -8.3% | 167,869 | +0.6% | 0.03% | -15.0% |
Q4 2022 | $6,593 | -99.9% | 166,819 | +2.8% | 0.04% | -7.0% |
Q3 2022 | $6,522,000 | -0.1% | 162,319 | +4.5% | 0.04% | +4.9% |
Q2 2022 | $6,528,000 | +39.8% | 155,289 | +29.6% | 0.04% | +57.7% |
Q1 2022 | $4,668,000 | -4.3% | 119,823 | -2.1% | 0.03% | 0.0% |
Q4 2021 | $4,879,000 | +10.4% | 122,433 | +0.1% | 0.03% | 0.0% |
Q3 2021 | $4,420,000 | -4.7% | 122,303 | +8.0% | 0.03% | -3.7% |
Q2 2021 | $4,640,000 | -9.6% | 113,194 | -3.7% | 0.03% | -15.6% |
Q1 2021 | $5,130,000 | +156.2% | 117,604 | +194.0% | 0.03% | +146.2% |
Q4 2020 | $2,002,000 | +52.4% | 40,004 | +28.1% | 0.01% | +30.0% |
Q3 2020 | $1,314,000 | – | 31,240 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 2,680,644 | $106,824,000 | 67.12% |
SIGULER GUFF ADVISERS, LLC | 6,761,970 | $269,465,000 | 56.37% |
Vantage Consulting Group Inc | 4,601,152 | $183,355,000 | 49.30% |
Indie Asset Partners, LLC | 805,982 | $32,118,000 | 23.31% |
HARVARD MANAGEMENT CO INC | 3,464,990 | $138,080,000 | 12.96% |
Brown University | 621,759 | $24,777,000 | 6.04% |
Overbrook Management Corp | 729,125 | $29,056,000 | 5.86% |
Bleichroeder LP | 824,033 | $32,838,000 | 5.13% |
Geo Capital Gestora de Recursos Ltd | 200,692 | $7,998,000 | 3.81% |
Lagoda Investment Management, L.P. | 140,435 | $5,596,000 | 2.65% |